about
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideProlactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancerSteroid hormones, steroid receptors, and breast cancer stem cellsMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersEmergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsTOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsGene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic valueOpportunities for improving triple‐negative breast cancer outcomes: results of a population‐based studyHarnessing the complexity of gene expression data from cancer: from single gene to structural pathway methodsDouble-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data setsActivity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMolecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype.Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.The co-factor of LIM domains (CLIM/LDB/NLI) maintains basal mammary epithelial stem cells and promotes breast tumorigenesis.A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterizationThe lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancyMolecular characterisation of cell line models for triple-negative breast cancers.FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cellsCoagulation factor VII is regulated by androgen receptor in breast cancer.Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systemsGenomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.Pollutants in pet dogs: a model for environmental links to breast cancerTOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.Breast cancer - one term, many entities?Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study.Prognostic and predictive value of PDL1 expression in breast cancer.Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivoMolecular heterogeneity in adjacent cells in triple-negative breast cancer.Breast cancer subtype predictors revisited: from consensus to concordance?APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancerFunctional characterization of the 19q12 amplicon in grade III breast cancers
P2860
Q21195191-FE2EDA00-CEFF-4D98-A736-7ECF16C63D60Q21195199-694E5AFE-F676-4B4C-8DDC-879EA12B8170Q26799113-2628EDEB-4C0B-4214-AADA-5CCFB1846863Q26822406-50F40126-B6A8-41AC-8684-711082575C23Q26860518-38DA4149-D757-4235-AC65-DC647B4C457DQ27330524-48B07D44-B85A-46D4-8A9C-D90B19076800Q28393898-528615AE-79DB-4649-9578-ED98E8B36E34Q28488319-18F48A9B-C6D6-48DD-9D43-FB3917E1759EQ29248325-3C40E78E-3740-4ABF-B459-EBDF142BF462Q30580995-8571C4D0-225F-4FC4-B495-E1CEDF4FE1C3Q31141334-19F7FB9D-A84C-4426-855B-F170AC49734DQ33608593-60FF1A47-E208-443E-83D8-DFC6CBD1AC5EQ33739841-05855F7B-A209-4B73-A65A-C785DB4C2040Q33757096-55E3161A-D9F4-476D-AB94-E6012EE22950Q33767021-B793F394-68A1-419D-8BF2-055E02FCD7B5Q33778306-32A687C2-BBD4-4FF2-8935-73BCFD62249FQ33981658-F2D469FB-3BD0-4BDB-BB5A-AB93E5F17B31Q34150752-BF66CB13-73ED-4B08-A239-845B6EF9EA56Q34339847-BE85F25E-975A-4745-87C1-A958DF236DD8Q34451892-1246CFCE-85EC-47FC-B440-6E787B940A9DQ34476551-B81DF630-F9B3-45BB-97EF-64753C35C40DQ34497523-BF947293-72A5-4395-90FB-B56DB0CFDEA5Q34558816-2A4B27F5-0CD2-4F64-AF65-09E2E69B5A25Q34956648-B0C8278D-FD00-4F0F-A1A5-D61F74C0A2A2Q34995790-21A86F96-C588-4723-BAE3-84730F495200Q35005300-55328E04-E9BB-40FB-BC5E-F3904EED6385Q35021646-2B8FB9E2-9BF6-4231-B6EF-7305C7B0AD14Q35028021-A3581FF0-CC77-4673-96D1-956EFB4CE37FQ35074030-A656A32E-F094-4D8F-AF44-E99F88639530Q35370118-B97D1D94-0563-48C5-8D58-063A85C01778Q35657566-07076EAE-1DEF-4DBA-9373-DD637967EF59Q35741710-501B52CC-DF8F-4640-B3E5-7A1DDE7DE1D8Q35742631-1DC98DEB-D276-4AD8-AD8D-DA713198FDA6Q35904255-D7F627DA-092E-4979-8080-43929D7C040FQ35946392-4B57F737-A7A6-48C0-A42D-A26833CF1366Q35965925-C7C264E7-B118-43EE-A2A8-1CD3160C6012Q36040448-1B4A32B2-A903-4752-8151-638CFB7A602AQ36133842-9E2B11CF-0159-43BA-9AE2-522573832752Q36181412-64FFEC79-64C1-4A2C-B954-31B1F988D910Q36245567-A8063AA4-C26D-49B9-8DE9-A446BC2465A0
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A refined molecular taxonomy of breast cancer.
@ast
A refined molecular taxonomy of breast cancer.
@en
type
label
A refined molecular taxonomy of breast cancer.
@ast
A refined molecular taxonomy of breast cancer.
@en
prefLabel
A refined molecular taxonomy of breast cancer.
@ast
A refined molecular taxonomy of breast cancer.
@en
P2093
P2860
P356
P1433
P1476
A refined molecular taxonomy of breast cancer.
@en
P2093
A L Martin
A de Reynies
D Birnbaum
F Bertrand
F Bertucci
F Lerebours
G MacGrogan
P2860
P2888
P304
P356
10.1038/ONC.2011.301
P407
P577
2011-07-25T00:00:00Z